“…21 In these studies, no significant change was observed on physical and neurologic examinations, electroencephalography, and CSF findings of patients following CE-MRC with Ͻ1 mL of intrathecal Gd injection. 2,6,9,10,[12][13][14][15][16][17][22][23][24][25][26] Gd-DTPA has been reported as the safest and most recommended intrathecal contrast agent in human studies. 2,4,6,9,10 In our cohort of approximately 100 patients who had CE-MRC for at past 7 years in 2 different centers, we have not encountered a major complication.…”